Advertisement
U.S. markets closed
Advertisement

Eiger BioPharmaceuticals, Inc. (EIGR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
0.3401-0.0049 (-1.42%)
At close: 04:00PM EST
0.3571 +0.02 (+5.00%)
After hours: 04:44PM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/1/2023
Current
9/30/20236/30/20233/31/202312/31/20229/30/2022
Market Cap (intraday)
14.74M13.51M31.18M39.73M52.01M331.68M
Enterprise Value
16.25M572.41k-3.66M-19.02M-29.44M229.24M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
1.040.872.072.773.2620.93
Price/Book (mrq)
0.870.880.880.720.663.22
Enterprise Value/Revenue
1.110.18-0.79-4.62-10.9256.97
Enterprise Value/EBITDA
-0.20-0.030.190.891.23-8.88

Trading Information

Stock Price History

Beta (5Y Monthly) 1.89
52-Week Change 3-92.38%
S&P500 52-Week Change 312.18%
52 Week High 34.6100
52 Week Low 30.2100
50-Day Moving Average 30.3115
200-Day Moving Average 30.8354

Share Statistics

Avg Vol (3 month) 3340.25k
Avg Vol (10 day) 3160.47k
Shares Outstanding 544.38M
Implied Shares Outstanding 644.38M
Float 835.53M
% Held by Insiders 111.73%
% Held by Institutions 162.35%
Shares Short (Nov 14, 2023) 41.01M
Short Ratio (Nov 14, 2023) 42.93
Short % of Float (Nov 14, 2023) 42.72%
Short % of Shares Outstanding (Nov 14, 2023) 42.28%
Shares Short (prior month Oct 12, 2023) 41.07M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Mar 22, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Sep 29, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-527.52%

Management Effectiveness

Return on Assets (ttm)-52.43%
Return on Equity (ttm)-225.93%

Income Statement

Revenue (ttm)14.67M
Revenue Per Share (ttm)0.33
Quarterly Revenue Growth (yoy)-20.30%
Gross Profit (ttm)11.65M
EBITDA -83.35M
Net Income Avi to Common (ttm)-86.65M
Diluted EPS (ttm)-1.9500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)44.43M
Total Cash Per Share (mrq)1
Total Debt (mrq)40.94M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.31
Book Value Per Share (mrq)-0.04

Cash Flow Statement

Operating Cash Flow (ttm)-82.84M
Levered Free Cash Flow (ttm)-52.16M